Evidence map›Paper›PMID 30293194›Full record

ReviewApplied microbiology and biotechnology2018

Safety of the fungal workhorses of industrial biotechnology: update on the mycotoxin and secondary metabolite potential of Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei.

Jens C Frisvad, Lars L H Møller, Thomas O Larsen, Ravi Kumar, José Arnau

Open access · bronzeAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 261 papers.

0numbers the graph read from it
0cells of the map it votes in
261citing papers in PubMed
28.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

261 citing papers in PubMed, 342 citations in OpenAlex.

  1. Article
  2. Article
  3. Safety evaluation of the food enzyme cellulase from the genetically modifiedEFSA journal. European Food Safety Authority · 2026
    Article
  4. Article
  5. Safety evaluation of the food enzyme oryzin from the non-genetically modifiedEFSA journal. European Food Safety Authority · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Integrated bioprocess optimization of cellulase and xylanase production by Penicillium argillaceum using lignocellulosic agro-industrial residues.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

201 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jens C FrisvadDepartment of Biotechnology and Biomedicine (DTU Bioengineering), Technical University of Denmark, Søltofts Plads, B. 221, 2800, Kongens Lyngby, Denmark. jcf@bio.dtu.dk.ORCID http://orcid.org/0000-0002-0573-4340
Lars L H MøllerDepartment of Product Safety, Novozymes A/S, Krogshoejvej 36, 2880, Bagsvaerd, Denmark.
Thomas O LarsenDepartment of Biotechnology and Biomedicine (DTU Bioengineering), Technical University of Denmark, Søltofts Plads, B. 221, 2800, Kongens Lyngby, Denmark.
Ravi KumarDepartment of Genomics and Bioinformatics, Novozymes Inc., 1445 Drew Ave., Davis, CA, 95618, USA.
José ArnauDepartment of Fungal Strain Technology and Strain Approval Support, Novozymes A/S, Krogshoejvej 36, 2880, Bagsvaerd, Denmark.
Novozymes (Denmark) · DKTechnical University of Denmark · DKNovozymes (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review presents an update on the current knowledge of the secondary metabolite potential of the major fungal species used in industrial biotechnology, i.e., Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei. These species have a long history of safe use for enzyme production. Like most microorganisms that exist in a challenging environment in nature, these fungi can produce a large variety and number of secondary metabolites. Many of these compounds present several properties that make them attractive for different industrial and medical applications. A description of all known secondary metabolites produced by these species is presented here. Mycotoxins are a very limited group of secondary metabolites that can be produced by fungi and that pose health hazards in humans and other vertebrates when ingested in small amounts. Some mycotoxins are species-specific. Here, we present scientific basis for (1) the definition of mycotoxins including an update on their toxicity and (2) the clarity on misclassification of species and their mycotoxin potential reported in literature, e.g., A. oryzae has been wrongly reported as an aflatoxin producer, due to misclassification of Aspergillus flavus strains. It is therefore of paramount importance to accurately describe the mycotoxins that can potentially be produced by a fungal species that is to be used as a production organism and to ensure that production strains are not capable of producing mycotoxins during enzyme production. This review is intended as a reference paper for authorities, companies, and researchers dealing with secondary metabolite assessment, risk evaluation for food or feed enzyme production, or considerations on the use of these species as production hosts.

Indexed as

Aspergillus nigerAspergillus oryzaeIndustrial MicrobiologyMycotoxinsSecondary MetabolismTrichodermaMycotoxinsIndustrial enzymesMycotoxinsSafetySecondary metabolites

Identifiers

PMID30293194
PMCPMC6208954
OpenAlexW2895083798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.